In the coming years, as organizations increasingly prioritize the consumer experience in their business plans, innovation will largely be driven by shifts in consumer preferences, according to Sara Deshpande, partner at Maven Ventures and a lecturer at the Stanford (Calif.)…
Innovation
Innovation in healthcare often requires a technology component and significant cultural change. As a result, it's not always possible on a tight timeline.
Highmark Health and subsidiary Allegheny Health Network, both in Pittsburgh, announced on Jan. 15 the expansion of their longtime collaboration with Baltimore-based Johns Hopkins Medicine, creating one of the nation's largest women's health-focused research initiatives.
Here are seven hospitals and health systems that have distributed innovation funds — to startups, internal projects and venture funds — in the last two weeks, beginning with the most recent:
UPMC's innovation, commercialization and venture capital arm plans to funnel a total of $1 billion into the development of new drugs, diagnostics and devices by 2024, the Pittsburgh-based health system announced Jan. 14.
The American Medical Association announced on Jan. 14 an initiative launched in partnership with investment platform RedCrow to build collaborations between physicians and healthcare startups.
An analytics-driven platform will be Mayo Clinic Platform's first venture, with an aim of using advanced data analytics and artificial intelligence to develop new treatments for disease, Rochester, Minn.-based Mayo Clinic announced Jan. 14.
Over the past couple years, "innovation" has become a strategic imperative for many hospitals and health systems, but what exactly is innovation — and how can leaders sustain innovative changes in their organizations long-term?
The Small Business Innovation Research program, which sets aside federal funds for promising early-stage companies, must be strengthened if the U.S. hopes to continue producing massively successful tech giants, argues an op-ed in The Hill.
R. Martin Chavez, PhD, a former Goldman Sachs executive who left the investment bank at the end of 2019, has joined the board of directors of Paige, a startup developing artificial intelligence for cancer diagnosis and treatment.